TuisRHO • ETR
add
Roche Holding AG
Vorige sluiting
€402,00
Dagwisseling
€387,60 - €392,00
Jaarwisseling
€272,60 - €420,80
Markkapitalisasie
357,50Â mjd USD
Gemiddelde volume
369,00
P/V-verhouding
-
Dividend-opbrengs
-
In die nuus
ROG
2,93%
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CHF) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 15,75Â mjd | -0,42% |
Bedryfskoste | 6,82Â mjd | -6,61% |
Netto inkomste | 2,74Â mjd | 170,93% |
Netto winsgrens | 17,36 | 172,10% |
Wins per aandeel | — | — |
EBITDA | 5,50Â mjd | 5,93% |
Effektiewe belastingkoers | 19,20% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CHF) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 15,49Â mjd | -10,66% |
Totale bates | 100,70Â mjd | -1,08% |
Totale aanspreeklikheid | 62,82Â mjd | -4,29% |
Totale ekwiteit | 37,88 mjd | — |
Uitstaande aandele | 795,62 m | — |
Prys om te bespreek | 9,46 | — |
Opbrengs op bates | 11,73% | — |
Opbrengs op kapitaal | 16,62% | — |
Kontantvloei
Netto kontantverandering
| (CHF) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 2,74Â mjd | 170,93% |
Kontant van bedrywe | 5,88Â mjd | -3,51% |
Kontant van beleggings | -5,19Â mjd | -21,67% |
Kontant van finansiering | -1,62Â mjd | -136,86% |
Netto kontantverandering | -986,00Â m | -191,68% |
Beskikbare kontantvloei | 2,53Â mjd | 15,49% |
Meer oor
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
Gestig
01 Okt. 1896
Hoofkwartier
Webwerf
Werknemers
112Â 774